NVCT – nuvectis pharma, inc. (US:NASDAQ)

News

Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights [Yahoo! Finance]
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC [Yahoo! Finance]
Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com